Related Experiment Video
Updated: Mar 12, 2026

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
20.1K
Increasing Emergency Department Visits for Anaphylaxis, 2005-2014
Megan S Motosue1, M Fernanda Bellolio2, Holly K Van Houten3
1Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.
The Journal of Allergy and Clinical Immunology. in Practice
|November 8, 2016
Summary
Emergency department visits for anaphylaxis doubled from 2005 to 2014, with the largest increases seen in children. This trend highlights a growing public health concern for allergic reactions.
Area of Science:
- Allergy and Immunology
- Public Health
- Emergency Medicine
Background:
- Anaphylaxis is a severe, potentially fatal systemic allergic reaction.
- Previous studies indicated rising anaphylaxis incidence, but recent US emergency department (ED) trends were unexamined.
Purpose of the Study:
- To analyze trends in anaphylaxis-related emergency department (ED) visits in the United States between 2005 and 2014.
- To identify demographic and trigger-specific changes in anaphylaxis ED visits over time.
Main Methods:
- Retrospective analysis of a national administrative claims database (commercially insured and Medicare Advantage).
- Calculation of anaphylaxis ED visit rates per 100,000 enrollees.
- Comparison of rates over time, by age group, and by identified trigger.
Main Results:
- Anaphylaxis ED visits increased by 101% from 2005 to 2014 (14.2 to 28.6 per 100,000).
- Rates surged in all age groups, with the most significant rise (196%) in children aged 5-17.
- Food-related anaphylaxis visits rose by 124%, and medication-related visits by 212%.
Conclusions:
- Emergency department visits for anaphylaxis significantly increased nationwide from 2005 to 2014.
- Children experienced the most substantial increase in anaphylaxis-related ED visits.
- The findings underscore a growing public health challenge associated with anaphylaxis.
Related Concept Videos
Allergic Reactions: Anaphylaxis
110
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
110
Allergic Reactions
33.2K
Overview
33.2K
Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Adrenergic Agonists: Therapeutic Uses
2.1K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.1K
Drug Toxicity: Allergic Reactions
85
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
85
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K

